June 23 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said on Wednesday that its CEO Ognyan Donev acquired 106,291 shares in the company at a weighted average price of 3.65 levs ($2.23/1.87 euro) apiece.